Australian biotech raises an additional $50 million for AMD drug
Melbourne-based biotech company Opthea has announced it has secured commitments from both Australian and international investors for an additional $50 ...
Tag: trials
Melbourne-based biotech company Opthea has announced it has secured commitments from both Australian and international investors for an additional $50 ...